285 related articles for article (PubMed ID: 12364441)
1. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.
Straczkowski M; Dzienis-Straczkowska S; Stêpieñ A; Kowalska I; Szelachowska M; Kinalska I
J Clin Endocrinol Metab; 2002 Oct; 87(10):4602-6. PubMed ID: 12364441
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
[TBL] [Abstract][Full Text] [Related]
4. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway.
Fernandez-Real JM; Broch M; Vendrell J; Ricart W
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1552-6. PubMed ID: 12975637
[TBL] [Abstract][Full Text] [Related]
5. Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.
Fernandez-Real JM; Pugeat M; Grasa M; Broch M; Vendrell J; Brun J; Ricart W
J Clin Endocrinol Metab; 2002 Oct; 87(10):4686-90. PubMed ID: 12364459
[TBL] [Abstract][Full Text] [Related]
6. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab.
Di Rocco P; Manco M; Rosa G; Greco AV; Mingrone G
Obes Res; 2004 Apr; 12(4):734-9. PubMed ID: 15090644
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.
Straczkowski M; Kowalska I; Stepien A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I
Diabetes Care; 2002 Oct; 25(10):1824-8. PubMed ID: 12351485
[TBL] [Abstract][Full Text] [Related]
8. Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity.
Straczkowski M; Lewczuk P; Dzienis-Straczkowska S; Kowalska I; Stepień A; Kinalska I
Metabolism; 2002 Jan; 51(1):75-8. PubMed ID: 11782876
[TBL] [Abstract][Full Text] [Related]
9. Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance.
Straczkowski M; Kowalska I; Dzienis-Straczkowska S; Stepién A; Skibińska E; Szelachowska M; Kinalska I
Eur J Endocrinol; 2001 Sep; 145(3):273-80. PubMed ID: 11517007
[TBL] [Abstract][Full Text] [Related]
10. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study.
Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B
Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
[TBL] [Abstract][Full Text] [Related]
13. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.
Vilarrasa N; Vendrell J; Sánchez-Santos R; Broch M; Megia A; Masdevall C; Gomez N; Soler J; Pujol J; Bettónica C; Aranda H; Gómez JM
Clin Endocrinol (Oxf); 2007 Nov; 67(5):679-86. PubMed ID: 17608757
[TBL] [Abstract][Full Text] [Related]
14. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.
Corica F; Allegra A; Corsonello A; Buemi M; Calapai G; Ruello A; Nicita Mauro V; Ceruso D
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):355-60. PubMed ID: 10340812
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity.
Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Janowska J; Zurakowski A
Metabolism; 2004 Oct; 53(10):1268-73. PubMed ID: 15375781
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble tumor necrosis factor-alpha receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity.
Rönnemaa T; Pulkki K; Kaprio J
J Clin Endocrinol Metab; 2000 Aug; 85(8):2728-32. PubMed ID: 10946872
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.
Gupta A; Ten S; Anhalt H
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):75-82. PubMed ID: 15679072
[TBL] [Abstract][Full Text] [Related]
20. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
Ohara S; Komatsu R; Matsuyama T
Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
